In a trial of semaglutide, people who switched to a placebo regained around 7% of their body weight over the following year, while those who kept taking the medication lost a further 8%
doi: 10.1074/jbc.M111.310342 28 KosiborodMNAbildstrmSZBorlaugBAButlerJRasmussenSDaviesMet al
Additionally, heart disease is complicated, and while semaglutide may help to improve various risk factors causally linked to the condition, such as high blood sugar and obesity, it cant impact all other risk factors, such as smoking, lack of physical activity, and poor emotional health
After four weeks, the dose typically increases to 0.5mg per week for another four weeks, then continues titrating upward
Once the fat cells are destroyed, they can no longer store fat
Subclinical compromise in cardiac strain relates to lower cognitive performances in older adults